Cargando…

Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review

OBJECTIVES: Effective and non-invasive biomarkers to predict and avoid posthepatectomy liver failure (PHLF) are urgently needed. This systematic review aims to evaluate the efficacy of gadoxetic acid–enhanced MRI-derived parameters as an imaging biomarker in preoperative prediction of PHLF. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Wang, Anrong, Sparrelid, Ernesto, Zhang, Jiaxing, Zhao, Ying, Ma, Kuansheng, Brismar, Torkel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831250/
https://www.ncbi.nlm.nih.gov/pubmed/34562137
http://dx.doi.org/10.1007/s00330-021-08297-8
_version_ 1784648464465920000
author Wang, Qiang
Wang, Anrong
Sparrelid, Ernesto
Zhang, Jiaxing
Zhao, Ying
Ma, Kuansheng
Brismar, Torkel B.
author_facet Wang, Qiang
Wang, Anrong
Sparrelid, Ernesto
Zhang, Jiaxing
Zhao, Ying
Ma, Kuansheng
Brismar, Torkel B.
author_sort Wang, Qiang
collection PubMed
description OBJECTIVES: Effective and non-invasive biomarkers to predict and avoid posthepatectomy liver failure (PHLF) are urgently needed. This systematic review aims to evaluate the efficacy of gadoxetic acid–enhanced MRI-derived parameters as an imaging biomarker in preoperative prediction of PHLF. METHODS: A systematic literature search was performed in the databases of PubMed/Medline, Web of Science, Embase, and Cochrane Library up to 11 December 2020. Studies evaluating the incidence of PHLF on patients who underwent hepatectomy with preoperative liver function assessment using gadoxetic acid–enhanced MRI were included. Data was extracted using pre-designed tables. The Quality In Prognostic Studies (QUIPS) tool was adopted to evaluate the risk of bias. RESULTS: A total of 15 studies were identified for qualitative synthesis and most studies were marked as low to moderate risk of bias in each domain of QUIPS. The most commonly used parameter was relative liver enhancement or its related parameters. The reported incidence of PHLF ranged from 3.9 to 40%. The predictive sensitivity and specificity of gadoxetic acid–enhanced MRI parameters varied from 75 to 100% and from 54 to 93% in ten reported studies. A majority of the studies revealed that the gadoxetic acid–enhanced MRI parameter was a predictor for PHLF. CONCLUSIONS: Gadoxetic acid–enhanced MRI showed a high predictive capacity for PHLF and represents a promising imaging biomarker in prediction of PHLF. Multicenter, prospective trials with large sample size and reliable, unified liver function parameters are required to validate the efficacy of individual liver function parameters. KEY POINTS: • There is an obvious heterogeneity of the published studies, not only in variance of MRI liver function parameters but also in indication and extent of the liver resection. • Signal intensity (SI)–based parameters derived from gadoxetic acid–enhanced MRI are the commonly used method for PHLF prediction. • Gadoxetic acid–enhanced MRI-derived parameters showed high predictive efficacy for PHLF and can potentially serve as a predictor for the incidence of PHLF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08297-8.
format Online
Article
Text
id pubmed-8831250
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88312502022-03-02 Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review Wang, Qiang Wang, Anrong Sparrelid, Ernesto Zhang, Jiaxing Zhao, Ying Ma, Kuansheng Brismar, Torkel B. Eur Radiol Gastrointestinal OBJECTIVES: Effective and non-invasive biomarkers to predict and avoid posthepatectomy liver failure (PHLF) are urgently needed. This systematic review aims to evaluate the efficacy of gadoxetic acid–enhanced MRI-derived parameters as an imaging biomarker in preoperative prediction of PHLF. METHODS: A systematic literature search was performed in the databases of PubMed/Medline, Web of Science, Embase, and Cochrane Library up to 11 December 2020. Studies evaluating the incidence of PHLF on patients who underwent hepatectomy with preoperative liver function assessment using gadoxetic acid–enhanced MRI were included. Data was extracted using pre-designed tables. The Quality In Prognostic Studies (QUIPS) tool was adopted to evaluate the risk of bias. RESULTS: A total of 15 studies were identified for qualitative synthesis and most studies were marked as low to moderate risk of bias in each domain of QUIPS. The most commonly used parameter was relative liver enhancement or its related parameters. The reported incidence of PHLF ranged from 3.9 to 40%. The predictive sensitivity and specificity of gadoxetic acid–enhanced MRI parameters varied from 75 to 100% and from 54 to 93% in ten reported studies. A majority of the studies revealed that the gadoxetic acid–enhanced MRI parameter was a predictor for PHLF. CONCLUSIONS: Gadoxetic acid–enhanced MRI showed a high predictive capacity for PHLF and represents a promising imaging biomarker in prediction of PHLF. Multicenter, prospective trials with large sample size and reliable, unified liver function parameters are required to validate the efficacy of individual liver function parameters. KEY POINTS: • There is an obvious heterogeneity of the published studies, not only in variance of MRI liver function parameters but also in indication and extent of the liver resection. • Signal intensity (SI)–based parameters derived from gadoxetic acid–enhanced MRI are the commonly used method for PHLF prediction. • Gadoxetic acid–enhanced MRI-derived parameters showed high predictive efficacy for PHLF and can potentially serve as a predictor for the incidence of PHLF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08297-8. Springer Berlin Heidelberg 2021-09-25 2022 /pmc/articles/PMC8831250/ /pubmed/34562137 http://dx.doi.org/10.1007/s00330-021-08297-8 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Gastrointestinal
Wang, Qiang
Wang, Anrong
Sparrelid, Ernesto
Zhang, Jiaxing
Zhao, Ying
Ma, Kuansheng
Brismar, Torkel B.
Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title_full Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title_fullStr Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title_full_unstemmed Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title_short Predictive value of gadoxetic acid–enhanced MRI for posthepatectomy liver failure: a systematic review
title_sort predictive value of gadoxetic acid–enhanced mri for posthepatectomy liver failure: a systematic review
topic Gastrointestinal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831250/
https://www.ncbi.nlm.nih.gov/pubmed/34562137
http://dx.doi.org/10.1007/s00330-021-08297-8
work_keys_str_mv AT wangqiang predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT wanganrong predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT sparrelidernesto predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT zhangjiaxing predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT zhaoying predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT makuansheng predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview
AT brismartorkelb predictivevalueofgadoxeticacidenhancedmriforposthepatectomyliverfailureasystematicreview